Matthew Schniederjan, MD
Surgery · Amarillo, TXNPI 1295945152
Payments from drug & device makers
Across 235 payments — averaging $390.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$64K
- Medical Device Business Services, Inc.$19K
- Covidien LP$6K
- Johnson & Johnson$2K
- Intuitive Surgical$1K
- Vertex$92
- plus $343 from 11 others
What the payments were for
- Consulting fees$33,79937%
- Speaking & faculty fees$49,75054%
- Travel & lodging$1,1711%
- Food & beverage$7,1048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 140 | $64,070 |
| Medical Device Business Services, Inc. | 22 | $18,807 |
| Covidien LP | 16 | $5,953 |
| Johnson & Johnson(2 entities) | 28 | $1,550 |
| Intuitive Surgical | 7 | $1,010 |
| Vertex | 4 | $92 |
| Novo Nordisk | 4 | $65 |
| Ambu Inc. | 2 | $51 |
| Enterra Medical, Inc. | 2 | $49 |
| Zimmer Biomet | 1 | $30 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| Baudax Bio Inc. | 2 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $21 |
| Cook Medical LLC | 1 | $20 |
| Nalpropion Pharmaceuticals LLC | 1 | $15 |
| Apollo Endosurgery US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Echelon Flex$12,369
- STRATAFIX$10,080
- LigaSure$7,449
- ECHELON FLEX Stapler$6,566
- Sonicision$1,200
- Signia$922
- Da Vinci Surgical System$917
- LINX Reflux Management System$307
- Endo GIA$107
- Signet$101
How this compares
$91,824 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lansoprazole | 51 | $1,025 |
| Sucralfate | 31 | $572 |
| Celecoxib | 24 | $370 |
| Ondansetron OdtOndansetron | 30 | $315 |
| Pantoprazole Sodium | 13 | $132 |
| Pregabalin | 12 | $72 |
| Omeprazole | 13 | $48 |
| Tramadol Hcl | 18 | $38 |
Paid to pharmacies, not to this prescriber.
Other surgery in Amarillo
- Bo NeichoyAmarillo$209K
- Darren PetersonAmarillo$148K
- Funda MericHouston$20.6M
- Michael HarkinsTomball$2.7M
- Lloyd StegemannCorpus Christi$1.9M
- Douglas StoddardAustin$1.4M
- Erik WilsonBellaire$1.2M
- Thomas SerenaShenandoah$1.2M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$924K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.